tiprankstipranks
ABVC BioPharma, Inc. (ABVC)
NASDAQ:ABVC
US Market
ABVC
ABVC BioPharma
RESEARCH TOOLSreports
Want to see ABVC full AI Analyst Report?

ABVC BioPharma (ABVC) Income Statement

127 Followers

ABVC BioPharma Income Statement

Last quarter (Q4 2025), ABVC BioPharma's total revenue was $-795.95K, a decrease of -40585.76% from the same quarter last year. In Q4, ABVC BioPharma's net income was $-3.56M. See ABVC BioPharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Mar 23Mar 22
Total Revenue
$ 795.95K$ 509.59K$ 152.43K$ 969.78K$ 355.80K
Gross Profit
$ 795.95K$ 508.83K$ -149.61K$ 683.37K$ 350.71K
Operating Expenses
$ 6.65M$ 5.21M$ 6.62M$ 15.80M$ 12.06M
Depreciation and Amortization
$ 504.83K$ 200.92K$ 380.39K$ 23.80K$ 11.99K
EBITDA
$ -6.65M$ -4.34M$ -6.33M$ -15.20M$ -10.97M
Operating Income
$ -7.15M$ -4.71M$ -6.77M$ -15.11M$ -11.71M
Other Income/Expenses
$ -1.20M$ -664.33K$ -1.26M$ -400.18K$ 495.14K
Pretax Income
$ -8.35M$ -5.37M$ -8.02M$ -15.51M$ -11.21M
Net Income
$ -7.91M$ -4.90M$ -7.79M$ -16.42M$ -12.84M
Per Share Metrics
Basic EPS
$ -0.39$ -0.42$ -1.80$ -5.20$ -5.10
Diluted EPS
$ -0.39$ -0.42$ -1.80$ -5.20$ -5.10
Weighted Average Shares Outstanding
 23.26M 11.67M 4.34M 3.17M 2.51M
Weighted Average Shares Outstanding (Diluted)
 23.26M 11.67M 4.34M 3.17M 2.51M
Currency in USD

ABVC BioPharma Earnings and Revenue History